Skip to content

Telemonitoring System for Patients with Diabetes: a randomised controlled trial.

Telemonitoring System for Patients with Diabetes: a randomised controlled trial. - Telemonitoring System for Patients with Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000011204
Enrollment
100
Registered
2013-07-16
Start date
2009-11-16
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabettes, impaired glucose tolerance

Interventions

Intervention group: Home telemonitoring system using multi-functional mobile phone for 3 months 1) Every day: records of meals(photos), body weight, amount of exercise(number of steps, blood pressu

Sponsors

Kanazawa University Hospital,Department of Endocrinology and Metabolism
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with untreated diabetes or impaired glucose tolerance 2) HbA1C 5.2~6.4% 3) Patients with untreated hypertension or dyslipidemia 4) Patients whose content is obtained in written form

Exclusion criteria

Exclusion criteria: 1) Patients with malignant hypertension or secondary hypertension 2) Diabetic patients requiring medical treatment 3) Pregnant and probably pregnant patients 4) patients with abnormal serum creatinin value 5) Patients with severe hepatic dysfunction 6) Patients who had myocardial infarction or apoplexy within 3 months before the satrt of the study or who are treated. 7) Patients with severe allergy or with treatment by steroid 8) Patients with pancreatitis or pasthistory of pancreatitis 9) Patients with malignacy 10) other patients judged as being inappropriate for the subjects of the study by investigators

Design outcomes

Primary

MeasureTime frame
following items before and 3 months after the introduction of home telemonitoring system 1 plasma glucose level, HbA1C 2 Urine alubumin excretion 3 Lipid levels 4 Blood pressure 5 Body weight, Body Mass Index 6 Diabetic complication 7 newly required medicine for diabetes, blood pressure, or dyslipidemia

Countries

Japan

Contacts

Public ContactTakashi Yoneda

Kanazawa University Kanazawa University Hospital

+81762652252

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026